When multiple myeloma relapses

RESPOND with deeper response with Kyprolis®-based regimen (Kd)

Kd complete response

In the ENDEAVOR trial, twice as many patients achieved CR or better with Kd vs Vd.1

Adapted from Dimopoulos et al.1

Kyprolis® has a tolerable safety profile in combination with dexamethasone

*Descriptive P value.

Please read the SmPC for full comprehensive safety information

References

  1. Dimopoulos MA et al. Lancet Oncol 2016;17:27–38.

Terms of Use

The information contained in this site is for European healthcare professionals only.

Kyprolis